Vanda Pharmaceuticals | VNDA - Pre Tax Profit


Vanda Pharmaceuticals reported $-22.92M in Pre-Tax Profit for its fiscal quarter ending in December of 2024.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 26.32M 18.28M Dec/2025
Agios Pharmaceuticals USD -109.06M 5.62M Dec/2025
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alnylam Pharmaceuticals USD 161.14M 77.83M Dec/2025
Anika Therapeutics USD -3.87M 32.43M Mar/2025
Arrowhead Research USD 28.27M 7.85M Dec/2025
AstraZeneca USD 3.24B 117M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
Enanta Pharmaceuticals USD -22.71M 95.08M Dec/2024
Esperion Therapeutics USD 67.66M 3.6M Sep/2024
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Heron Therapeutics USD -4.85M 4.39M Sep/2024
Insmed USD -326.93M 41.77M Dec/2025
J&J USD 4.97B 2.53B Dec/2025
Lexicon Pharmaceuticals USD -53.43M 5.03M Jun/2024
Ligand Pharmaceuticals USD 141.14M 102M Sep/2025
Merck USD 6.74B 22M Sep/2025
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Moderna USD -187M 631M Sep/2025
Novartis USD 5.17B 637M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
PTC Therapeutics USD -139.08M 116.01M Dec/2025
Puma Biotechnology USD 20.61M 24.76M Sep/2024
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sanofi EUR -1.16B 5.5B Dec/2025
Takeda JPY 133.86B 105.69B Dec/2025
Teva Pharmaceutical Industries USD 91M 555M Dec/2025
Ultragenyx Pharmaceutical USD -128M 51.54M Dec/2025
Vanda Pharmaceuticals USD -22.92M 16.68M Dec/2024
Veracyte USD 40.63M 21.74M Dec/2025